Loring Wolcott & Coolidge Fiduciary Advisors’s St Jude Medical STJ Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,300	Closed	-$101K	–	657
2016 Q2	$101K	Hold	1,300	–	–	﹤0.01%	325
2016 Q1	$72K	Hold	1,300	–	–	﹤0.01%	350
2015 Q4	$80K	Hold	1,300	–	–	﹤0.01%	363
2015 Q3	$95K	Hold	1,300	–	–	﹤0.01%	361
2015 Q2	$95K	Hold	1,300	–	–	﹤0.01%	361
2015 Q1	$85K	Hold	1,300	–	–	﹤0.01%	380
2014 Q4	$85K	Hold	1,300	–	–	﹤0.01%	372
2014 Q3	$78K	Hold	1,300	–	–	﹤0.01%	367
2014 Q2	$90K	Buy	+1,300	New	+$84.3K	﹤0.01%	369

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's STJ Position: Q3 2016 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 1,300 shares — an estimated $101K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in STJ in Q2 2014 and held it in 9 quarters. The position peaked at $101K in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 1,300 St Jude Medical shares in Q3 2016, an estimated $101K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in St Jude Medical in Q2 2014 and held it in 9 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's St Jude Medical position peaked at $101K in Q2 2016.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2016, filed 1 Nov 2016.